Inflammation and transcriptional responses of peripheral blood mononuclear cells in classic ataxia telangiectasia
Sharon A McGrath-Morrow, Roland Ndeh, Joseph M Collaco, Cynthia Rothblum-Oviatt, Jennifer Wright, Michael A O'Reilly, Benjamin D Singer, Howard M Lederman, Sharon A McGrath-Morrow, Roland Ndeh, Joseph M Collaco, Cynthia Rothblum-Oviatt, Jennifer Wright, Michael A O'Reilly, Benjamin D Singer, Howard M Lederman
Abstract
Introduction: Classic ataxia telangiectasia (A-T) is an autosomal recessive disease characterized by early onset ataxia, immune deficiency, sino-pulmonary disease, lymphoid/solid malignancies and telangiectasias. Prior studies have suggested that chronic inflammation and premature aging may contribute to the development of malignancy and pulmonary disease in people with A-T. To further examine the link between A-T and inflammation, we hypothesized that subjects with classic A-T would have greater enrichment of inflammatory pathways in peripheral blood mononuclear cells (PBMCs) compared to non A-T age-matched controls. To test this hypothesis we used RNAseq as an unsupervised approach to identify biological processes altered in people with classic A-T.
Methods: PBMCs were isolated from subjects with classic A-T and compared to non-A-T age-matched healthy controls. RNAseq with differential gene expression analyses was then performed. Selected genes were validated by RT-qPCR using cohorts of subjects consisting of classic A-T, mild A-T or non-A-T controls. Subjects with mild A-T were characterized by later onset/mild neurologic features and normal/near normal immune status.
Results: RNAseq revealed 310 differentially expressed genes (DEGs) including genes involved in inflammation, immune regulation, and cancer. Using gene set enrichment analysis, A-T subjects were found to have biological processes enriched for inflammatory and malignancy pathways. In examining a cohort of A-T subjects in which baseline serum IL8 and IL6 levels were measured previously, an association was found between higher serum IL8 levels and higher likelihood of developing malignancy and/or death in a subsequent 4-6 year period.
Conclusion: RNAseq using PBMCs from subjects with classic A-T uncovered differential expression of immune response genes and biological processes associated with inflammation, immune regulation, and cancer. Follow-up of A-T subjects over a 4-6 year period revealed an association between higher baseline serum IL8 levels and malignancy/death. These findings support a role for inflammation as a contributing factor in A-T phenotypes.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
References
- Nakamura K, Fike F, Haghayegh S, Saunders-Pullman R, Dawson AJ, Dork T, et al. A-TWinnipeg: Pathogenesis of rare ATM missense mutation c.6200C>A with decreased protein expression and downstream signaling, early-onset dystonia, cancer, and life-threatening radiotoxicity. Molecular genetics & genomic medicine. 2014;2(4):332–40. Epub 2014/08/01. 10.1002/mgg3.72
- Staples ER, McDermott EM, Reiman A, Byrd PJ, Ritchie S, Taylor AM, et al. Immunodeficiency in ataxia telangiectasia is correlated strongly with the presence of two null mutations in the ataxia telangiectasia mutated gene. Clin Exp Immunol. 2008;153(2):214–20. 10.1111/j.1365-2249.2008.03684.x
- Zaki-Dizaji M, Akrami SM, Azizi G, Abolhassani H, Aghamohammadi A. Inflammation, a significant player of Ataxia-Telangiectasia pathogenesis? Inflamm Res. 2018. 10.1007/s00011-018-1142-y
- Giuliani A, Prattichizzo F, Micolucci L, Ceriello A, Procopio AD, Rippo MR. Mitochondrial (Dys) Function in Inflammaging: Do MitomiRs Influence the Energetic, Oxidative, and Inflammatory Status of Senescent Cells? Mediators Inflamm. 2017;2017:2309034 10.1155/2017/2309034
- Campisi J, Andersen JK, Kapahi P, Melov S. Cellular senescence: a link between cancer and age-related degenerative disease? Semin Cancer Biol. 2011;21(6):354–9. 10.1016/j.semcancer.2011.09.001
- Kang C, Xu Q, Martin TD, Li MZ, Demaria M, Aron L, et al. The DNA damage response induces inflammation and senescence by inhibiting autophagy of GATA4. Science. 2015;349(6255):aaa5612. 10.1126/science.aaa5612
- Watanabe S, Kawamoto S, Ohtani N, Hara E. Impact of senescence-associated secretory phenotype and its potential as a therapeutic target for senescence-associated diseases. Cancer Sci. 2017;108(4):563–9. Epub 2017/02/07. 10.1111/cas.13184 .
- Tsukamoto H, Fujieda K, Senju S, Ikeda T, Oshiumi H, Nishimura Y. Immune-suppressive effects of interleukin-6 on T-cell-mediated anti-tumor immunity. Cancer Sci. 2018;109(3):523–30. Epub 2017/11/02. 10.1111/cas.13433 .
- Jin WJ, Xu JM, Xu WL, Gu DH, Li PW. Diagnostic value of interleukin-8 in colorectal cancer: a case-control study and meta-analysis. World journal of gastroenterology. 2014;20(43):16334–42. Epub 2014/12/05. 10.3748/wjg.v20.i43.16334 .
- McGrath-Morrow SA, Collaco JM, Crawford TO, Carson KA, Lefton-Greif MA, Zeitlin P, et al. Elevated serum IL-8 levels in ataxia telangiectasia. J Pediatr. 2010;156(4):682–4. 10.1016/j.jpeds.2009.12.007
- McGrath-Morrow SA, Collaco JM, Detrick B, Lederman HM. Serum Interleukin-6 Levels and Pulmonary Function in Ataxia-Telangiectasia. J Pediatr. 2016. 10.1016/j.jpeds.2016.01.002
- Mavrou A, Tsangaris GT, Roma E, Kolialexi A. The ATM gene and ataxia telangiectasia. Anticancer Res. 2008;28(1B):401–5.
- Suarez F, Mahlaoui N, Canioni D, Andriamanga C, Dubois dEC, Brousse N, et al. Incidence, presentation, and prognosis of malignancies in ataxia-telangiectasia: a report from the French national registry of primary immune deficiencies. J Clin Oncol. 2015;33(2):202–8. 10.1200/JCO.2014.56.5101
- Gumy-Pause F, Wacker P, Sappino AP. ATM gene and lymphoid malignancies. Leukemia. 2004;18(2):238–42. 10.1038/sj.leu.2403221
- Jerzak KJ, Mancuso T, Eisen A. Ataxia-telangiectasia gene (ATM) mutation heterozygosity in breast cancer: a narrative review. Current oncology (Toronto, Ont). 2018;25(2):e176–e80. Epub 2018/05/03. 10.3747/co.25.3707 .
- van Os NJ, Roeleveld N, Weemaes CM, Jongmans MC, Janssens GO, Taylor AM, et al. Health risks for ataxia-telangiectasia mutated heterozygotes: a systematic review, meta-analysis and evidence-based guideline. Clin Genet. 2016;90(2):105–17. 10.1111/cge.12710
- Fang EF, Bohr VA. NAD(+): The convergence of DNA repair and mitophagy. Autophagy. 2017;13(2):442–3. Epub 2016/12/09. 10.1080/15548627.2016.1257467
- Schubert R, Erker L, Barlow C, Yakushiji H, Larson D, Russo A, et al. Cancer chemoprevention by the antioxidant tempol in Atm-deficient mice. Human molecular genetics. 2004;13(16):1793–802. Epub 2004/06/24. 10.1093/hmg/ddh189 .
- Kozlowski M, Ladurner AG. ATM, MacroH2A.1, and SASP: The Checks and Balances of Cellular Senescence. Mol Cell. 2015;59(5):713–5. 10.1016/j.molcel.2015.08.010
- Cabana MD, Crawford TO, Winkelstein JA, Christensen JR, Lederman HM. Consequences of the delayed diagnosis of ataxia-telangiectasia. Pediatrics. 1998;102(1 Pt 1):98–100. Epub 1998/07/04. .
- Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319–38. 10.1183/09031936.05.00034805
- Wang X, Dockery DW, Wypij D, Fay ME, Ferris BG, Jr. Pulmonary function between 6 and 18 years of age. Pediatr Pulmonol. 1993;15(2):75–88.
- Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med. 1999;159(1):179–87. 10.1164/ajrccm.159.1.9712108
- McGrath-Morrow S, Ndeh R, Helmin KA, Chen SY, Anekalla KR, Abdala-Valencia H, et al. DNA methylation regulates the neonatal CD4+ T-cell response to pneumonia in mice. The Journal of biological chemistry. 2018. Epub 2018/06/06. 10.1074/jbc.RA118.003589 .
- Liberzon A, Birger C, Thorvaldsdottir H, Ghandi M, Mesirov JP, Tamayo P. The Molecular Signatures Database (MSigDB) hallmark gene set collection. Cell systems. 2015;1(6):417–25. Epub 2016/01/16. 10.1016/j.cels.2015.12.004 .
- Schoenaker MHD, Van Os NJH, Van der Flier M, Van Deuren M, Seyger MM, Taylor AMR, et al. Telangiectasias in Ataxia Telangiectasia: Clinical significance, role of ATM deficiency and potential pathophysiological mechanisms. European journal of medical genetics. 2018;61(5):284–7. Epub 2017/12/31. 10.1016/j.ejmg.2017.12.012 .
- Takada H, Imoto I, Tsuda H, Nakanishi Y, Ichikura T, Mochizuki H, et al. ADAM23, a possible tumor suppressor gene, is frequently silenced in gastric cancers by homozygous deletion or aberrant promoter hypermethylation. Oncogene. 2005;24(54):8051–60. 10.1038/sj.onc.1208952
- Hunter JE, Butterworth JA, Zhao B, Sellier H, Campbell KJ, Thomas HD, et al. The NF-kappaB subunit c-Rel regulates Bach2 tumour suppressor expression in B-cell lymphoma. Oncogene. 2016;35(26):3476–84. 10.1038/onc.2015.399
- Gorczynski RM, Zhu F. Checkpoint blockade in solid tumors and B-cell malignancies, with special consideration of the role of CD200. Cancer management and research. 2017;9:601–9. Epub 2017/11/29. 10.2147/CMAR.S147326 .
- Zhu YM, Bradbury DA, Pang L, Knox AJ. Transcriptional regulation of interleukin (IL)-8 by bradykinin in human airway smooth muscle cells involves prostanoid-dependent activation of AP-1 and nuclear factor (NF)-IL-6 and prostanoid-independent activation of NF-kappaB. The Journal of biological chemistry. 2003;278(31):29366–75. Epub 2003/05/16. 10.1074/jbc.M301785200
- Elizondo DM, Andargie TE, Marshall KM, Zariwala AM, Lipscomb MW. Dendritic cell expression of ADAM23 governs T cell proliferation and cytokine production through the alpha(v)beta(3) integrin receptor. J Leukoc Biol. 2016;100(5):855–64. 10.1189/jlb.2HI1115-525R
- Mohan V, Sullivan CS, Guo J, Wade SD, Majumder S, Agarwal A, et al. Temporal Regulation of Dendritic Spines Through NrCAM-Semaphorin3F Receptor Signaling in Developing Cortical Pyramidal Neurons. Cerebral cortex (New York, NY: 1991). 2018. Epub 2018/02/08. 10.1093/cercor/bhy004 .
- Chan JY, Ong CW, Salto-Tellez M. Overexpression of neurone glial-related cell adhesion molecule is an independent predictor of poor prognosis in advanced colorectal cancer. Cancer Sci. 2011;102(10):1855–61. 10.1111/j.1349-7006.2011.02021.x
- Dhodapkar KM, Friedlander D, Scholes J, Grumet M. Differential expression of the cell-adhesion molecule Nr-CAM in hyperplastic and neoplastic human pancreatic tissue. Hum Pathol. 2001;32(4):396–400. 10.1053/hupa.2001.23526
- Rodenas-Cuadrado P, Ho J, Vernes SC. Shining a light on CNTNAP2: complex functions to complex disorders. European journal of human genetics: EJHG. 2014;22(2):171–8. Epub 2013/05/30. 10.1038/ejhg.2013.100 .
- Becker EB, Zuliani L, Pettingill R, Lang B, Waters P, Dulneva A, et al. Contactin-associated protein-2 antibodies in non-paraneoplastic cerebellar ataxia. Journal of neurology, neurosurgery, and psychiatry. 2012;83(4):437–40. Epub 2012/02/18. 10.1136/jnnp-2011-301506 .
- Bianchi A, Gervasi ME, Bakin A. Role of beta5-integrin in epithelial-mesenchymal transition in response to TGF-beta. Cell Cycle. 2010;9(8):1647–59. Epub 2010/04/21. 10.4161/cc.9.8.11517
- Bianchi-Smiraglia A, Paesante S, Bakin AV. Integrin beta5 contributes to the tumorigenic potential of breast cancer cells through the Src-FAK and MEK-ERK signaling pathways. Oncogene. 2013;32(25):3049–58. Epub 2012/07/25. 10.1038/onc.2012.320
- Correia NC, Arcangeli ML, Pflumio F, Barata JT. Stem Cell Leukemia: how a TALented actor can go awry on the hematopoietic stage. Leukemia. 2016;30(10):1968–78. Epub 2016/07/23. 10.1038/leu.2016.169 .
- El-Mokhtar MA, Bauer A, Madela J, Voigt S. Cellular distribution of CD200 receptor in rats and its interaction with cytomegalovirus e127 protein. Medical microbiology and immunology. 2018. Epub 2018/07/23. 10.1007/s00430-018-0552-3 .
- Afzali B, Gronholm J, Vandrovcova J, O’Brien C, Sun HW, Vanderleyden I, et al. BACH2 immunodeficiency illustrates an association between super-enhancers and haploinsufficiency. Nat Immunol. 2017;18(7):813–23. 10.1038/ni.3753
- Casamassimi A, Federico A, Rienzo M, Esposito S, Ciccodicola A. Transcriptome Profiling in Human Diseases: New Advances and Perspectives. International journal of molecular sciences. 2017;18(8). Epub 2017/08/02. 10.3390/ijms18081652 .
- Menotta M, Orazi S, Gioacchini AM, Spapperi C, Ricci A, Chessa L, et al. Proteomics and transcriptomics analyses of ataxia telangiectasia cells treated with Dexamethasone. PloS one. 2018;13(4):e0195388 Epub 2018/04/03. 10.1371/journal.pone.0195388 .
- Menotta M, Biagiotti S, Orazi S, Rossi L, Chessa L, Leuzzi V, et al. In vivo effects of dexamethasone on blood gene expression in ataxia telangiectasia. Molecular and cellular biochemistry. 2018;438(1–2):153–66. Epub 2017/07/27. 10.1007/s11010-017-3122-x .
- Mortazavi A, Williams BA, McCue K, Schaeffer L, Wold B. Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nature methods. 2008;5(7):621–8. Epub 2008/06/03. 10.1038/nmeth.1226 .
Source: PubMed